Global vaccines research

You can find our latest insights and opinions below.

News & polls | Articles & papers | Webinars, videos & podcasts | Services

News & polls

Data Dive: How the COVID-19 pandemic shaped views - Global polling insights about the coronavirus crisis’ impact on everything, including views on vaccines. October 2022

Covid-19: Expectations and vaccination - A survey for the World Economic Forum finds the majority of people believe we’ll never fully stop the spread of COVID, but views on vaccination mandates vary. February 2022

Articles & papers

RSV: The race to market continues – Several companies remain key contenders to launch the first respiratory syncytial virus (RSV) vaccine

RSV: On the verge of change – After decades of failed attempts, the respiratory syncytial virus (RSV) treatment and vaccine landscape is on the verge of profound change.

Expanding Flu Vaccine Access - Polling commissioned by AstraZeneca on Ipsos’ KnowledgePanel® found that broadening the availability of a nasal spray to those not already vaccinated could increase flu vaccine uptake for children and adults under the age of 50. 

Awareness of HPV Among Parents - MSD commissioned Ipsos to run a survey to support speakers at the European Week Against Cancer, taking place from 25 – 31 May 2022. The findings demonstrate the need to further boost HPV awareness and knowledge, to lead to greater vaccine uptake and ultimately lower the prevalence of cancer-causing HPV 

Infographic: COVID-19: Vaccines, therapeutics & treatment impact – Perspectives from Ipsos's syndicated COVID-19 study portfolio.

Responding to Covid-19 in Africa: Finding the balance - Ipsos conducted public opinion polls on behalf of the Partnership for Evidence-Based Response to COVID-19 (PERC) in 19 African Union Member States to understand the public’s knowledge, risk perception, attitudes, access to information, reactions, behaviours and practices related to COVID-19. This report distills key insights from PERC’s fourth survey conducted in September 2021. 

Webinars, videos & podcasts

Understanding the drivers of infant immunisation – In this 6-part series, Ipsos shares what stood out for them from nearly three years of research surrounding barriers to infant immunisation in sub-Saharan Africa 

KEYS – The year in review: Making sense of 2021 - 2021 started with a mood of guarded optimism and at least some hope that the storm which came with Covid-19 could now be weathered. As the year drew to a close, Ipsos reflected on how people were feeling about this 12-month period and any lessons learned to take forward.

Services

Click here to learn more about Ipsos’ global vaccines research capabilities, and how we can help answer your key questions: 

• Ipsos’ Global Syndicated Vaccine Study - Healthcare professionals, paediatricians, pharmacists and consumers

• Ipsos’ Global Syndicated RSV Study – An extension of the Syndicated Vaccine Study covering attitudes and perceptions around RSV vaccination & immunisation